Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Genetic Technologies ( (AU:GTG) ) has shared an update.
Genetic Technologies Limited has announced the quotation of 26,493,450 ordinary fully paid securities on the Australian Securities Exchange (ASX). This move is part of previously announced transactions and is expected to enhance the company’s market presence and liquidity, potentially benefiting stakeholders by increasing the company’s financial flexibility and operational capacity.
More about Genetic Technologies
Genetic Technologies Limited operates in the biotechnology industry, focusing on genetic testing and diagnostics. The company is known for its development of predictive genetic tests, which are aimed at assessing the risk of various diseases, thereby contributing to personalized healthcare solutions.
Technical Sentiment Signal: Sell
Current Market Cap: A$9.45M
For detailed information about GTG stock, go to TipRanks’ Stock Analysis page.